Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
January 21, 2020 - The FDA announced the approval of Horizon Therapeutics’ Tepezza (teprotumumab-trbw), for the treatment of thyroid eye disease (TED).
Return to publications